Somalia vs Suriname: HIV/AIDS deaths averted by antiretroviral therapy
Somalia
336.41 deaths
in 2022
Suriname
331.73 deaths
in 2024
Somalia rank
98th
Suriname rank
101st
HIV/AIDS deaths averted by antiretroviral therapy over time
- Somalia
- Suriname
How they compare
Somalia currently reports 336.41 deaths against 331.73 deaths in Suriname, a difference of 4.68 deaths.
The two have swapped places 5 times across 33 shared years of data; in 1990 it was Suriname ahead.
Somalia ranks 98th and Suriname ranks 101st of 157 countries.
Across the 4 decades both report, Somalia averaged higher in 1 and Suriname in 2.
Head to head by decade
| Decade | Somalia | Suriname | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 33.63 deaths | 69.65 deaths | 36.03 deaths | Suriname |
| 2010s | 264.05 deaths | 266.44 deaths | 2.39 deaths | Suriname |
| 2020s | 331.82 deaths | 293.13 deaths | 38.69 deaths | Somalia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Somalia or Suriname?
- Somalia, at 336.41 deaths against 331.73 deaths in Suriname as of 2022.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Somalia and Suriname?
- 4.68 deaths, with Somalia ahead.
- How many years of comparable data are there for Somalia and Suriname?
- 33 years are reported by both, from 1990 to 2022.
- How do Somalia and Suriname rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Somalia ranks 98th and Suriname ranks 101st of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.